NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Biologics Supports DiaMedica’s New Treatment for Chronic Kidney Disease
Jan 23, 2020
Catalent today welcomed the news that DiaMedica Therapeutics has received U.S. FDA approval to commence Phase 2 clinical trials of its lead candidate, DM199, for chronic kidney disease.
Catalent to Discuss Ways of Increasing Accuracy and Speed in Assay Development at CASSS WCBP Symposium
Jan 21, 2020
Catalent today announced that Christopher Hepler, Manager, Catalent Biologics Analytical Development, has been invited to speak on ways to improve assay development at the upcoming CASSS WCBP symposium, which will be held on Jan 28 – 30, 2020.
Catalent Further Strengthens Biologics Business with Key Senior Appointments
Jan 16, 2020
Catalent today announced the appointment of Karen Flynn as President of Biologics and Chief Commercial Officer. Ms. Flynn has also joined the company’s Executive Leadership Team and will report to Alessandro Maselli, Catalent’s President and Chief Operating Officer.
Catalent Launches FlexDirect™ Direct-to-Patient Clinical Supply Services
Jan 14, 2020
Catalent, a global leader in clinical supply services, today announced the launch of FlexDirect™, a new direct-to-patient service for clinical trials.
Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy
Jan 7, 2020
Catalent today announced the completion of the purchase of Bristol-Myers Squibb’s biologics, sterile, and oral solid dose product manufacturing and packaging facility in Anagni, Italy.
Catalent to Host Workshop to Discuss Accelerating Early Drug Development through Consultant Collaboration
Dec 17, 2019
Catalent today announced it will host a workshop for drug development consultants titled, “How to Effectively Work with a Development Partner – From a Consultant Standpoint”, at its facility in San Diego, on Jan. 8, 2020.
Catalent Launches New CTSuccess™ Service to Guide Sponsors to Smarter Clinical Trial Supply Planning
Dec 12, 2019
Catalent today announced the launch of its new CTSuccess™ clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.
Catalent Partners with Bridge Therapeutics on Formulation, Development and Production of New Opioid Addiction Treatment
Dec 10, 2019
Catalent today announced that it has completed clinical production of Bridge Therapeutics Inc.’s opioid addiction development therapeutic product, BT-219, and executed an Exclusive Licensing Agreement to use Catalent’s proprietary Zydis® orally disintegrating tablet technology.
Catalent to Partner with Ethicann on New Fast-Dissolve Cannabinoid-Based Treatment for Multiple Sclerosis Spasticity
Dec 3, 2019
Catalent today announced that it has entered into a partnership with Ethicann to formulate a new combination pharmaceutical-grade CBD and THC product that, if approved, would treat patients suffering from multiple sclerosis spasticity.
CASSS WCBP
Date: January 28-30, 2020
Webinar | Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations
Date: January 29, 2019
Natural Product Expo West
Date: March 3-7, 2020
Setting Up Your Small Molecules and Biologics for Success
Date: March 5, 2020
CTS Europe
Date: March 11-12, 2020
Achieving Integrated Biologics Development
Date: March 12, 2020
Outsourcing Clinical Trials Israel 2020
Date: March 17-18, 2020
DCAT Week
Date: March 23-26, 2020
CTS New England
Date: March 24-25, 2020
BEBPA Bioassay Conference
Date: March 25-27, 2020
Master Class: How to Accelerate Early Drug Development in Oncology for Small Molecules and Biologics
Date: March 26, 2020
Drug Delivery Partnership
Date: March 30-April 1, 2020
In-Cosmetics Global
Date: March 31 – April 2, 2020
Drug Development Networking Summit
Date: April 16, 2020
CASSS BIOASSAY
Date: April 26-28, 2020
GCSG US Conference
Date: April 26-29, 2020
Interphex
Date: April 28-30, 2020
World Orphan Drug Congress
Date: April 29 – May 1, 2020